Diagnosis of Diabetes Mellitus

The diagnosis of diabetes mellitus is made through a blood sample. First, blood plasma is obtained — this is the liquid portion of the blood. The blood is drawn into a special tube that prevents clotting and contains substances that prevent blood glucose from breaking down.

A blood glucose value below 100 mg/dl (5.5 mmol/l) is normal. A person is considered diabetic if the fasting venous plasma glucose is above 126 mg/dl (7.0 mmol/l). Values between 100 and 126 mg/dl (5.5 and 7.0 mmol/l) indicate impaired fasting glucose, which suggests a prediabetic stage (prediabetes, impaired glucose tolerance).

A blood glucose level above 200 mg/dl (11.1 mmol/l) measured at any time of the day also indicates diabetes.

Oral Glucose Tolerance Test (OGTT) for Diabetes Detection

Another way to diagnose diabetes is the “oral glucose tolerance test” (OGTT) at the doctor’s office:

  • The patient ingests 75 grams of glucose while fasting.
  • Blood glucose is measured at regular intervals afterward.

If the blood glucose level is below 140 mg/dl (7.7 mmol/l) two hours after glucose ingestion, diabetes is ruled out. A value over 200 mg/dl (11.1 mmol/l) after two hours confirms diabetes. Values between 140 mg/dl and 200 mg/dl (7.7 and 11.1 mmol/l) indicate prediabetes/impaired

Diabetes Diagnosis via HbA1c Value

Today, the OGTT is often skipped in favor of simply measuring the HbA1c value.
The HbA1c is a fraction of hemoglobin (the red blood pigment) that has bound to glucose — commonly called the “long-term blood sugar value.” It reflects the average blood glucose over the past eight weeks.

  • Prediabetes / impaired glucose tolerance: HbA1c between 5.7% and 6.4%
  • Diabetes: HbA1c above 6.5%

However, there are several factors that can affect HbA1c (severe liver or kidney failure, hemolytic anemia, etc.). A confirmed diagnosis therefore requires both an elevated HbA1c and a pathologically elevated plasma glucose ≥ 200 mg/dl (≥ 11.1 mmol/l) [1].

Diagnostic testing should be carried out if typical diabetes symptoms are present.

Common Symptoms of Diabetes

  • Thirst
  • Visual disturbances
  • Frequent urination
  • Itching
  • Fatigue
  • Skin infections
  • Listlessness
  • Poor wound healing
  • Lack of drive
  • Genital infections
  • Weakness
  • Urinary tract infections
  • Loss of libido
  • Weight loss

If you have one or more of these symptoms, you should definitely see your doctor to have your blood sugar checked. Diabetes is often detected by chance, as slightly elevated blood glucose levels may not cause symptoms. Many people are diabetic without knowing it.

For people at increased risk of diabetes, occasional blood sugar checks are advisable. Increased risk applies to people with diabetic relatives or those who are overweight.

How to Distinguish Type 1 from Type 2 Diabetes

  • Type 1 Diabetes Mellitus:
    • Most patients are slim.
    • Symptoms appear suddenly.
    • Diagnosis is confirmed by measuring insulin and C-peptide — both are low.
    • As this is an autoimmune process, antibodies (GADA, ICA, IA-2, IA-2A) are usually present. Elevated antibody levels confirm type 1 diabetes.
  • Type 2 Diabetes Mellitus:
    • Most patients are overweight.
    • Often asymptomatic in early stages; diagnosed incidentally.
    • Usually part of metabolic syndrome with hypertension and dyslipidemia (which often occur before elevated blood sugar).
    • Insulin and C-peptide are elevated in the early stages, which rules out type 1 diabetes.
  • LADA (Latent Autoimmune Diabetes in Adults):
    • Can be difficult to diagnose.
    • Suspect LADA if oral medication works only briefly and insulin therapy is required soon after diagnosis.

ADA 2025 – Screening for Type 1 Diabetes

  • Test of choice:
    • Autoantibody panel against islet antigens, including:
      • GAD65 (glutamic acid decarboxylase)
      • IA-2 (insulinoma-associated protein 2)
      • ZnT8 (zinc transporter 8)
      • Insulin autoantibodies (IAA)
  • Target population:
    • First-degree relatives of people with type 1 diabetes.
    • Individuals from the general population at higher genetic risk (research/clinical programs).
  • Purpose: Detect Stage 1 or Stage 2 type 1 diabetes before hyperglycemia, so that:
    • Families can be educated.
    • Risk of diabetic ketoacidosis (DKA) at onset is reduced.
    • Early intervention trials can be considered (e.g., teplizumab).
  • No OGTT vs fasting glucose: OGTT can be used to stage presymptomatic T1D once multiple autoantibodies are found, but it is not a general screening tool for type 1 diabetes in the way it is for gestational diabetes.

Key ADA 2025 Statement

“Screening for presymptomatic type 1 diabetes should be accomplished with a panel of islet autoantibodies in those at increased risk.”
(ADA Standards of Care in Diabetes — 2025, Section 2, DOI: 10.2337/dc25-S002)

ADA (2025) Screening Recommendations for Type 2 Diabetes & Prediabetes

Who Should Be Screened & When?

  • All adults beginning at age 35, regardless of other risk factors.
  • Adults of any age with overweight or obesity (BMI ≥ 25 kg/m², or ≥ 23 kg/m² for Asian Americans) plus one or more additional risk factors, including:
    • First-degree relative with diabetes
    • High-risk race/ethnicity
    • Hypertension (130/80 mmHg or on therapy)
    • Cardiovascular disease (CVD)
    • Physical inactivity
    • Polycystic ovary syndrome (PCOS)
    • History of gestational diabetes
    • A1C ≥ 5.7%, impaired fasting glucose (IFG), or impaired glucose tolerance (IGT)
    • HDL < 35 mg/dL or triglycerides > 250 mg/dL
      Diabetes Journals+10Wikipedia+10Wikipedia+10wafp.orgWikipedia+2wafp.org+2

 

Frequency of Screening

  • Every 3 years if initial test is normal.
  • Annually if the person has prediabetes (e.g., A1C 5.7–6.4%), history of gestational diabetes, or other ongoing risk factors.
    Wikipedia+2wafp.org+2

 

Rationale & Scope

  • These recommendations apply to both type 2 diabetes and prediabetes, reflecting the continuum of metabolic risk.
  • The approach aligns with USPSTF guidance but broadens age and risk factor criteria.
    diabetes.org+15Wikipedia+15diaTribe+15

ADA 2025 Diagnostic Criteria – Type 2 Diabetes

A diagnosis of diabetes is made if any of the following is met (confirmed by repeat testing unless unequivocal hyperglycemia is present):

  1. Fasting plasma glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L)
    • Fasting = no caloric intake for at least 8 hours.
  2. 2-hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during a 75 g oral glucose tolerance test (OGTT).
    • This is where impaired glucose tolerance (IGT) comes in:
      • IGT = 2-hour OGTT plasma glucose 140–199 mg/dL (7.8–11.0 mmol/L).
      • Normal = 2-hour < 140 mg/dL.
  3. HbA1c ≥ 6.5% (48 mmol/mol) — must be performed in a lab using a method standardized to the DCCT assay.
  4. Random plasma glucose ≥ 200 mg/dL (11.1 mmol/L) in a person with classic symptoms of hyperglycemia or hyperglycemic crisis.

Prediabetes Categories (ADA 2025)

Test

Prediabetes Range

FPG

100–125 mg/dL (5.6–6.9 mmol/L) → impaired fasting glucose (IFG)

2-hour OGTT

140–199 mg/dL (7.8–11.0 mmol/L) → impaired glucose tolerance (IGT)

HbA1c

5.7–6.4%

Summary Table

Criteria

Recommendation

Age

All adults starting at age 35

Younger Adults

Any age with BMI ≥ 25 (≥ 23 for Asian Americans) + ≥1 risk factor

If Initial Test Normal

Re-screen every 3 years

If Prediabetes or High Risk

Re-screen annually

References: American Diabetes Association Professional Practice Committee Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025,

Diabetes Care 2025;48(Supplement_1):S27–S49

Keywords: thirst, visual disturbances, frequent urination, itching, fatigue, skin infections, listlessness, poor wound healing, lack of drive, genital infections, weakness, urinary tract infections, loss of libido, what is diabetes